These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1682459)

  • 1. Pharmacokinetics of valproic acid in guinea-pigs with biliary abnormality.
    Yu HY; Shen YZ
    J Pharm Pharmacol; 1991 Jul; 43(7):470-4. PubMed ID: 1682459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-dependent disposition of glucuronide metabolite of valproate.
    Yu HY; Shen YZ
    J Pharm Pharmacol; 2002 May; 54(5):633-9. PubMed ID: 12005358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interaction. Effects of salicylate on pharmacokinetics of valproic acid in rats.
    Yu HY; Shen YZ; Sugiyama Y; Hanano M
    Drug Metab Dispos; 1990; 18(1):121-6. PubMed ID: 1970771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent pharmacokinetics of valproate in guinea pigs of different ages.
    Yu HY; Shen YZ; Sugiyama Y; Hanano M
    Epilepsia; 1987; 28(6):680-7. PubMed ID: 3121286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in pharmacokinetics of valproic acid in guinea pigs from birth to maturity.
    Yu HY; Sugiyama Y; Hanano M
    Epilepsia; 1985; 26(3):243-51. PubMed ID: 3924587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent inhibition in plasma protein binding of valproic acid during continued treatment in guinea-pigs.
    Yu HY; Shen YZ
    J Pharm Pharmacol; 1992 May; 44(5):408-12. PubMed ID: 1359055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlinear elimination and hepatic concentration of conjugation-metabolite of valproate in guinea-pigs.
    Yu HY; Wu MS; Shen YZ
    Biopharm Drug Dispos; 1993 May; 14(4):297-312. PubMed ID: 8499581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent distribution volumes of total and unbound valproate in guinea-pigs: consequence of non-linear plasma protein binding.
    Yu HY; Shen YZ
    Biopharm Drug Dispos; 1996 Apr; 17(3):237-47. PubMed ID: 8983398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats.
    Kojima S; Nadai M; Kitaichi K; Wang L; Nabeshima T; Hasegawa T
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3136-40. PubMed ID: 9835504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: role of enterohepatic circulation.
    Kawakami J; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T
    J Pharm Sci; 1993 Mar; 82(3):301-5. PubMed ID: 8450426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of quinidine on digoxin distribution and elimination in guinea pigs.
    Sato J; Sawada Y; Iga T; Hanano M
    J Pharm Sci; 1983 Oct; 72(10):1137-41. PubMed ID: 6644558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
    Yamamura N; Imura K; Naganuma H; Nishimura K
    Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carbamazepine on valproic acid disposition in adult volunteers.
    Panesar SK; Orr JM; Farrell K; Burton RW; Kassahun K; Abbott FS
    Br J Clin Pharmacol; 1989 Mar; 27(3):323-8. PubMed ID: 2497766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of valproate on the pharmacokinetics of free and total plasma bilirubin in experimental hyperbilirubinemia in guinea pigs.
    Yu HY; Shen YZ
    J Pharm Sci; 1998 Jan; 87(1):21-4. PubMed ID: 9452963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
    Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits.
    Yokogawa K; Iwashita S; Kubota A; Sasaki Y; Ishizaki J; Kawahara M; Matsushita R; Kimura K; Ichimura F; Miyamoto K
    Pharm Res; 2001 Sep; 18(9):1320-6. PubMed ID: 11683247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state valproate pharmacokinetics during long term therapy.
    Eadie MJ; Heazlewood V; McKauge L; Tyrer JH
    Clin Exp Neurol; 1983; 19():183-91. PubMed ID: 6439443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired biliary elimination of beta-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers.
    Dickinson RG; Kluck RM; Wood BT; Eadie MJ; Hooper WD
    Drug Metab Dispos; 1986; 14(2):255-62. PubMed ID: 2870903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of route of administration and biliary excretion on the pharmacokinetics of isotretinoin in the dog.
    Cotler S; Chen S; Macasieb T; Colburn WA
    Drug Metab Dispos; 1984; 12(2):143-7. PubMed ID: 6144477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy.
    Ragueneau-Majlessi I; Levy RH; Brodie M; Smith D; Shah J; Grundy JS
    Clin Pharmacokinet; 2005; 44(5):517-23. PubMed ID: 15871637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.